These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9352343)

  • 1. Managing the behavioral and psychological signs and symptoms of dementia.
    Finkel SI
    Int Clin Psychopharmacol; 1997 Sep; 12 Suppl 4():S25-8. PubMed ID: 9352343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risperidone versus other atypical antipsychotic medication for schizophrenia.
    Gilbody SM; Bagnall AM; Duggan L; Tuunainen A
    Cochrane Database Syst Rev; 2000; (3):CD002306. PubMed ID: 10908551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind comparison of olanzapine versus risperidone in the acute treatment of dementia-related behavioral disturbances in extended care facilities.
    Fontaine CS; Hynan LS; Koch K; Martin-Cook K; Svetlik D; Weiner MF
    J Clin Psychiatry; 2003 Jun; 64(6):726-30. PubMed ID: 12823090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olanzapine: an updated review of its use in the management of schizophrenia.
    Bhana N; Foster RH; Olney R; Plosker GL
    Drugs; 2001; 61(1):111-61. PubMed ID: 11217867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An integrated analysis of acute treatment-emergent extrapyramidal syndrome in patients with schizophrenia during olanzapine clinical trials: comparisons with placebo, haloperidol, risperidone, or clozapine.
    Carlson CD; Cavazzoni PA; Berg PH; Wei H; Beasley CM; Kane JM
    J Clin Psychiatry; 2003 Aug; 64(8):898-906. PubMed ID: 12927004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conventional vs. newer antipsychotics in elderly patients.
    Jeste DV; Rockwell E; Harris MJ; Lohr JB; Lacro J
    Am J Geriatr Psychiatry; 1999; 7(1):70-6. PubMed ID: 9919323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative effectiveness study of risperidone and olanzapine in the treatment of schizophrenia.
    Ho BC; Miller D; Nopoulos P; Andreasen NC
    J Clin Psychiatry; 1999 Oct; 60(10):658-63. PubMed ID: 10549681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A risk-benefit assessment of risperidone for the treatment of behavioural and psychological symptoms in dementia.
    Zaudig M
    Drug Saf; 2000 Sep; 23(3):183-95. PubMed ID: 11005702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of risperidone, olanzapine, clozapine, and conventional antipsychotics on type 2 diabetes: findings from a large health plan database.
    Gianfrancesco FD; Grogg AL; Mahmoud RA; Wang RH; Nasrallah HA
    J Clin Psychiatry; 2002 Oct; 63(10):920-30. PubMed ID: 12416602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral Disorders in Dementia: Appropriate Nondrug Interventions and Antipsychotic Use.
    Reese TR; Thiel DJ; Cocker KE
    Am Fam Physician; 2016 Aug; 94(4):276-82. PubMed ID: 27548592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia.
    Kapur S; Zipursky RB; Remington G
    Am J Psychiatry; 1999 Feb; 156(2):286-93. PubMed ID: 9989565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A naturalistic comparison of clozapine, risperidone, and olanzapine in the treatment of bipolar disorder.
    Guille C; Sachs GS; Ghaemi SN
    J Clin Psychiatry; 2000 Sep; 61(9):638-42. PubMed ID: 11030483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of risperidone and olanzapine on the indications for clozapine.
    Ganguli R; Brar JS
    Psychopharmacol Bull; 1998; 34(1):83-7. PubMed ID: 9564203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse events related to olanzapine.
    Conley RR; Meltzer HY
    J Clin Psychiatry; 2000; 61 Suppl 8():26-9; discussion 30. PubMed ID: 10811240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of atypical antipsychotics in mood disorders.
    Weizman R; Weizman A
    Curr Opin Investig Drugs; 2001 Jul; 2(7):940-5. PubMed ID: 11757795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New antipsychotic agents].
    Olie JP; Ghaoui S; Bayle FJ
    Encephale; 1999 Nov; 25 Spec No 3():52-60. PubMed ID: 10598295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of atypical neuroleptics in child and adolescent psychiatry.
    Toren P; Laor N; Weizman A
    J Clin Psychiatry; 1998 Dec; 59(12):644-56. PubMed ID: 9921698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose glycine added to olanzapine and risperidone for the treatment of schizophrenia.
    Heresco-Levy U; Ermilov M; Lichtenberg P; Bar G; Javitt DC
    Biol Psychiatry; 2004 Jan; 55(2):165-71. PubMed ID: 14732596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risperidone: a review of its use in the management of the behavioural and psychological symptoms of dementia.
    Bhana N; Spencer CM
    Drugs Aging; 2000 Jun; 16(6):451-71. PubMed ID: 10939309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipsychotic drugs and relapse prevention.
    Marder SR
    Schizophr Res; 1999 Mar; 35 Suppl():S87-92. PubMed ID: 10190229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.